|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0011860,
umls-concept:C0030705,
umls-concept:C0031809,
umls-concept:C0061323,
umls-concept:C0087111,
umls-concept:C0205195,
umls-concept:C0242808,
umls-concept:C0332170,
umls-concept:C0332307,
umls-concept:C0521112,
umls-concept:C0907402,
umls-concept:C1707455
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-5-4
|
|
pubmed:abstractText |
To compare the incidence of nocturnal hypoglycemia and glycemic control following bedtime or morning insulin glargine (LANTUS; glargine) plus glimepiride.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0018-5043
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
172-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16673208-Adult,
pubmed-meshheading:16673208-Aged,
pubmed-meshheading:16673208-Aged, 80 and over,
pubmed-meshheading:16673208-Blood Glucose,
pubmed-meshheading:16673208-Body Mass Index,
pubmed-meshheading:16673208-Body Weight,
pubmed-meshheading:16673208-Diabetes Mellitus, Type 2,
pubmed-meshheading:16673208-Drug Therapy, Combination,
pubmed-meshheading:16673208-Female,
pubmed-meshheading:16673208-Hemoglobin A, Glycosylated,
pubmed-meshheading:16673208-Humans,
pubmed-meshheading:16673208-Hypoglycemia,
pubmed-meshheading:16673208-Hypoglycemic Agents,
pubmed-meshheading:16673208-Insulin,
pubmed-meshheading:16673208-Insulin, Long-Acting,
pubmed-meshheading:16673208-Male,
pubmed-meshheading:16673208-Middle Aged,
pubmed-meshheading:16673208-Sulfonylurea Compounds,
pubmed-meshheading:16673208-Time Factors,
pubmed-meshheading:16673208-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: an assessment of treatment flexibility.
|
|
pubmed:affiliation |
Munich Institute of Diabetes Research and 3 Medical Department, Krankenhaus München-Schwabing, Munich, Germany. eberhard.standl@lrz.uni-muenchen.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
